These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 12109215)

  • 1. Intracellular barriers to non-viral gene transfer.
    Lechardeur D; Lukacs GL
    Curr Gene Ther; 2002 May; 2(2):183-94. PubMed ID: 12109215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular routing of plasmid DNA during non-viral gene transfer.
    Lechardeur D; Verkman AS; Lukacs GL
    Adv Drug Deliv Rev; 2005 Apr; 57(5):755-67. PubMed ID: 15757759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleocytoplasmic transport of plasmid DNA: a perilous journey from the cytoplasm to the nucleus.
    Lechardeur D; Lukacs GL
    Hum Gene Ther; 2006 Sep; 17(9):882-9. PubMed ID: 16972756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer: how can the biological barriers be overcome?
    Escoffre JM; Teissié J; Rols MP
    J Membr Biol; 2010 Jul; 236(1):61-74. PubMed ID: 20623114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import.
    Vaughan EE; DeGiulio JV; Dean DA
    Curr Gene Ther; 2006 Dec; 6(6):671-681. PubMed ID: 17168698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy.
    Akita H; Ito R; Khalil IA; Futaki S; Harashima H
    Mol Ther; 2004 Mar; 9(3):443-51. PubMed ID: 15006612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies on the nuclear-targeted delivery of genes.
    Yao J; Fan Y; Li Y; Huang L
    J Drug Target; 2013 Dec; 21(10):926-39. PubMed ID: 23964565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLS bioconjugates for targeting therapeutic genes to the nucleus.
    Escriou V; Carrière M; Scherman D; Wils P
    Adv Drug Deliv Rev; 2003 Feb; 55(2):295-306. PubMed ID: 12564982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonviral vectors in the new millennium: delivery barriers in gene transfer.
    Nishikawa M; Huang L
    Hum Gene Ther; 2001 May; 12(8):861-70. PubMed ID: 11387052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial viruses: exploiting viral trafficking for therapeutics.
    Glover DJ
    Infect Disord Drug Targets; 2012 Feb; 12(1):68-80. PubMed ID: 22034936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear pore complex is involved in nuclear transfer of plasmid DNA condensed with an oligolysine-RGD peptide containing nuclear localisation properties.
    Colin M; Moritz S; Fontanges P; Kornprobst M; Delouis C; Keller M; Miller AD; Capeau J; Coutelle C; Brahimi-Horn MC
    Gene Ther; 2001 Nov; 8(21):1643-53. PubMed ID: 11895003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA.
    Escriou V; Ciolina C; Helbling-Leclerc A; Wils P; Scherman D
    Cell Biol Toxicol; 1998 Mar; 14(2):95-104. PubMed ID: 9553720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear gene delivery: the Trojan horse approach.
    Rolland A
    Expert Opin Drug Deliv; 2006 Jan; 3(1):1-10. PubMed ID: 16370936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of endocytosis by non-viral vectors for efficient gene activity.
    Islam MA; Firdous J; Choi YJ; Yun CH; Cho CS
    J Biomed Nanotechnol; 2014 Jan; 10(1):67-80. PubMed ID: 24724499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer.
    Lechardeur D; Sohn KJ; Haardt M; Joshi PB; Monck M; Graham RW; Beatty B; Squire J; O'Brodovich H; Lukacs GL
    Gene Ther; 1999 Apr; 6(4):482-97. PubMed ID: 10476208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific and transcription factor-mediated nuclear entry of DNA.
    Miller AM; Dean DA
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):603-13. PubMed ID: 19393704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive drug delivery.
    Blömer U; Ganser A; Scherr M
    Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors.
    Carlisle RC; Bettinger T; Ogris M; Hale S; Mautner V; Seymour LW
    Mol Ther; 2001 Nov; 4(5):473-83. PubMed ID: 11708884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-viral gene delivery systems.
    Davis ME
    Curr Opin Biotechnol; 2002 Apr; 13(2):128-31. PubMed ID: 11950563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular trafficking of the cytoplasmic expression system.
    Brisson M; Tseng WC; Almonte C; Watkins S; Huang L
    Hum Gene Ther; 1999 Nov; 10(16):2601-13. PubMed ID: 10566888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.